Institutional Investors Sentiment Indicator of Parexel International Corp (NASDAQ:PRXL) Falls in Q2 2017

October 12, 2017 - By Lynda A. Deweese

 Institutional Investors Sentiment Indicator of Parexel International Corp (NASDAQ:PRXL)  Falls in  Q2 2017

Sentiment for Parexel International Corp (NASDAQ:PRXL)

Parexel International Corp (NASDAQ:PRXL) institutional sentiment decreased to 0.75 in 2017 Q2. Its down -0.19, from 0.94 in 2017Q1. The ratio has worsened, as 128 investment professionals opened new and increased holdings, while 170 trimmed and sold holdings in Parexel International Corp. The investment professionals in our partner’s database reported: 40.76 million shares, down from 47.35 million shares in 2017Q1. Also, the number of investment professionals holding Parexel International Corp in their top 10 holdings increased from 0 to 6 for an increase of 6. Sold All: 49 Reduced: 121 Increased: 67 New Position: 61.

PAREXEL International Corporation is a biopharmaceutical outsourcing services company. The company has market cap of $. The Firm provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology services and products to pharmaceutical, biotechnology and medical device industries. It currently has negative earnings. The Company’s divisions include Clinical Research Services (CRS), PAREXEL Consulting Services (PC) and PAREXEL Informatics (PI).

It is down 35.35% since October 12, 2016 and is uptrending. It has outperformed by 18.65% the S&P500.

Analysts await PAREXEL International Corporation (NASDAQ:PRXL) to report earnings on October, 25. They expect $0.89 earnings per share, up 17.11 % or $0.13 from last year’s $0.76 per share. After $1.02 actual earnings per share reported by PAREXEL International Corporation for the previous quarter, Wall Street now forecasts -12.75 % negative EPS growth.

Glazer Capital Llc holds 4.47% of its portfolio in PAREXEL International Corporation for 807,043 shares. Water Island Capital Llc owns 1.06 million shares or 4.34% of their US portfolio. Moreover, Omni Partners Llp has 3.32% invested in the company for 298,030 shares. The New York-based Kellner Capital Llc has invested 2.45% in the stock. Twin Securities Inc., a New York-based fund reported 175,000 shares.#img1#

PAREXEL International Corporation (NASDAQ:PRXL) Ratings Coverage

Ratings analysis reveals 6% of Parexel International’s analysts are positive. Out of 17 Wall Street analysts rating Parexel International, 1 give it “Buy”, 3 “Sell” rating, while 13 recommend “Hold”. The lowest target is $49 while the high is $88.1000. The stock’s average target of $70.64 is 0.00% above today’s ($0) share price. PRXL was included in 38 notes of analysts from August 7, 2015. Evercore upgraded the stock to “Outperform” rating in Monday, May 15 report. The firm has “Equal-Weight” rating given on Thursday, November 17 by First Analysis. The rating was maintained by Deutsche Bank with “Hold” on Friday, October 28. The firm has “Buy” rating by Mizuho given on Tuesday, May 30. The company was maintained on Friday, August 7 by Deutsche Bank. As per Friday, August 14, the company rating was reinitiated by Credit Suisse. On Friday, December 16 the stock rating was downgraded by Goldman Sachs to “Sell”. As per Monday, April 11, the company rating was maintained by Avondale. SunTrust downgraded the stock to “Hold” rating in Friday, November 11 report. The stock has “Buy” rating by Evercore on Wednesday, January 6.

More news for PAREXEL International Corporation (NASDAQ:PRXL) were recently published by:, which released: “PAREXEL International Receives Shareholder Approval for Proposed Acquisition …” on September 18, 2017.‘s article titled: “Pamplona completes take-private acquisition of Parexel” and published on October 02, 2017 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.